CING
CING
NASDAQ · Pharmaceuticals

Cingulate Inc

$4.94
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +191.1% upside
Low Target $9.95
Average Target $14.38
High Target $17.66
Current Price $4.94
Current
$4.94
Target
$14.38
$9.95 $14.38 avg $17.66
Scenario Analysis
Bear Case
$9.95
101.4%
Low target
Base Case
$14.38
+191.1%
Avg target
Bull Case
$17.66
+257.5%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$11.89
-58.5% from high
52-Week Low
$3.16
+56.3% from low
Target vs 52W High
$14.38
+20.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.4%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.7%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +31.4%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%